Legal Representation
Attorney
Lynn E. Rzonca
USPTO Deadlines 1 active 1 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OPPOSITION
Notice of Publication |
NPUB | Sep 22, 2022 | 1019 days overdue | Medium | Until Oct 22, 2022 |
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 8, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Nov 8, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Aug 23, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 23, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 3, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 15, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 15, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 3, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Nov 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 14, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Business management and consulting services for the health care industry, namely, business management of cell, gene and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks; business administration of cell, gene and other complex therapy programs
First Use Anywhere:
Mar 25, 2021
First Use in Commerce:
Mar 25, 2021
Class 044
Consulting services in the field of medical care, namely, developing medical treatment policies related to cell, gene, and other complex therapies; medical information services related to cell, gene and other complex therapies
First Use Anywhere:
Mar 25, 2021
First Use in Commerce:
Mar 25, 2021
Additional Information
Design Mark
The mark consists of stylized, wide ribbon, folding and forming a circle, directly to the left of the letters ETS.
Pseudo Mark
EMERGING THERAPY SOLUTIONS
Classification
International Classes
035
044